兰州大学循证社会科学交叉创新实验室 Innovation Laboratory of Evidence-based Social Sciences,Lanzhou University

Top-100 Most Cited Publications Concerning Network Pharmacology: A Bibliometric Analysis

Zhipeng Wei;Kehu Yang
2019-08-01
EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE
EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE
卷号:2019
ISSN:1741-427X|收录类别:SCIE
DOI
10.1155/2019/1704816
EISSN
1741-4288
出版日期
2019-08-01
关键词
ackground. Network pharmacology (NP) has become an increasingly important focus in the drug research field over the past decade. However, no study to date has mapped the current status of NP. Therefore, we performed a bibliometric study to evaluate the top 100 cited papers on NP. Methods. We searched the Web of Science Core Collection from its inception to February 25, 2019, using the terms network pharmacology and systems pharmacology. Key data, including title, publication year, number of citations, authors, countries/regions, organizations, and journals, were retrieved and analyzed using Excel 2016 and VOSviewer 1.6.10. Results. The total number of citations for the 100 cited papers ranged from 21 to 1,238, published in 53 journals, from 2005 to 2017. The top three journals with the most publications on NP were Clinical Pharmacology & Therapeutics (n=8, IF2017=6.544), Journal of Ethnopharmacology (n=8, IF2017=3.115), and PLoS One (n=7, IF2017=2.766). Most published articles were from the USA (n=41) and China (n=35). The most active author was Wang Yonghua from the Northwest A&F University, and of the 100 publications, 14 listing his name. The most frequently used substantive terms included drug discovery, traditional Chinese medicine (TCM), in-vitro, cancer, and cardiovascular disease. Conclusions. The USA and China made the greatest contribution to NP research. The current NP research mainly focused on NP methods (including experimental validation) and using them to explore the molecular mechanisms of TCM for some critical diseases such as cardiovascular diseases and cancers. Furthermore, we believe some guidelines should be developed to regulate NP studies.
资助信息
/
资助机构
/
相关链接
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6701366/
语种
英文
国家
中国
学科领域
循证药理学
WOS学科分类
Integrative & Complementary Medicine
被引频次(WOS)
36
来源机构
Evidence-Based Medicine Center, School of Basic Medical Sciences, Lanzhou University, Lanzhou, China;Evidence-based Social Science Center, School of Public Health, Lanzhou University, Lanzhou, China
研究类型
文献计量学